Navigation Links
Nutraceutical Reports 2007 Fiscal Year End Results
Date:11/29/2007

may cause our results to differ from these forward-looking statements include, but are not limited to, government regulations, product liability claims and litigation, insurance coverage issues, a decrease in or slowing of the growth rate of the vitamin, mineral and supplement market, the success of the healthy foods channel, consumer perception of safety and quality of our products and similar products, competition, intellectual property rights of other parties, the loss of key personnel, disruptions from acquisitions, issues with obtaining raw materials of adequate quality or quantity, problems with information management systems, manufacturing efficiencies and operations, litigation generally, the volatility of the stock market generally and of our stock specifically, a general lack of adequate industry analyst coverage, and other factors indicated from time to time in our SEC reports, copies of which are available upon request from our investor relations group or which may be obtained at the SEC's website (http://www.sec.gov).

NUTRACEUTICAL INTERNATIONAL CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited; dollars in thousands)

September 30, September 30,

2007 2006

Assets

Current assets, net $51,534 $44,437

Property, plant and equipment,

net 39,506 32,669

Goodwill 38,978 18,366

Other non-current assets, net 16,384 12,488

$146,402 $107,960

Liabilities and Stockholders' Equity

Current liabilities $20,
'/>"/>

SOURCE Nutraceutical International Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. New Nutraceutical That Stabilizes Blood Sugar Naturally is Introduced
2. New Nutraceutical Supplement Provides Simplified Approach to Diabetes Management Programs
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...A new immunosuppression regimen for heart transpla...t transplant coronary artery disease//, according ...ill report their findings on April 26 at The Inter...splantation Annual Meeting and Scientific Session ...
...An international research team, led by investigato...ancer Center and Dana-Farber Cancer Institute (DFC...come resistant to treatment with targeted therapy ...ch will appear in the journal Science and is recei...
...Results of a Japanese study have given drug gian... the study published in The Lancet, the company’s ...e the risks of strokes and cardiovascular events b...e Jikei Heart Study, was based on 3,000 people age...
...A simple scoring system based on five medical fact...dered for gastric bypass surgery would be at highe... first proposed last year by Duke University Medic... in a new study of more than 4,400 patients. The s...
Other Medicine News:Health News:Mayo Clinic Study Finds Heart Transplant Patients Benefit from New Approach to Immunosuppression 2Health News:New Mechanism Identified for Resistance to Targeted Lung Cancer Drugs 2Health News:New Mechanism Identified for Resistance to Targeted Lung Cancer Drugs 3Health News:Novartis Drug Diovan Shows Superior Benefits 2Health News:Simple System Accurately Predicts Weight-loss Surgery Risk 2Health News:Simple System Accurately Predicts Weight-loss Surgery Risk 3
(Date:10/7/2008)...Stage A of Trial Assessing Regimen of Bavituxim...-, TUSTIN, Calif., Oct. 7 /PRNewswire-FirstCall/ ...), a clinical stage biopharmaceutical,company deve...cancer and,hepatitis C virus (HCV) infection, toda...e first stage of a Phase II trial of bavituximab i...
(Date:10/6/2008)...irstCall/ -- Pharmasset, Inc.,(Nasdaq: VRUS ) ann...the,Company as Vice President of Investor Relation...responsible for all investor relations,functions a... Kurt,Leutzinger., Most recently, Dr. Smith was a...t JPMorgan Securities, and has been an analyst in ...
(Date:10/6/2008)... Scientific Conference -, ORLANDO, Fla., Oct. 6 /...Microbia) today announced presentation of data fro...le that cyclic guanosine,monophosphate (cGMP) play...monstrate that cGMP inhibits intestinal pain in a ...esensitizes colonic afferent nerves in a,similar m...
(Date:10/6/2008)...urezol Dosed Prior to Surgery, TAMPA, Fla., Oct. ...vately held ophthalmic-focused biopharmaceutical c...dnate ophthalmic emulsion) 0.05% is now,commercial....S. Food and,Drug Administration in June 2008, is ...the treatment of inflammation and pain associated ...
Breaking Medicine Technology:Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5New leukemia signal could point way to better treatment Stanford researchers find 26527 1New leukemia signal could point way to better treatment Stanford researchers find 26527 2 Caterpillar Logistics Services Retirees Win a Preliminary Injunction Providing Them Premium Free Retiree Healthcare 26525 1 Caterpillar Logistics Services Retirees Win a Preliminary Injunction Providing Them Premium Free Retiree Healthcare 26525 2 Caterpillar Logistics Services Retirees Win a Preliminary Injunction Providing Them Premium Free Retiree Healthcare 26525 3NJHA 3A Hospitals Achieve Gains in Healthcare Quality But Commitment to Improve Continues 26522 1NJHA 3A Hospitals Achieve Gains in Healthcare Quality But Commitment to Improve Continues 26522 2Message to North Carolina Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 26519 1Message to North Carolina Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 26519 2Message to North Carolina Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 26519 3
...d,today announced results from a study published i...that suggest infusions of a novel,new drug, CSL-11...terol) levels, may reduce the amount of plaque in ...isode of acute,coronary syndrome (ACS). , CSL advi...sclerosis – Safety and Efficacy (ERASE) tria...
...Interleukin,Genetics, Inc. (AMEX:ILI) and collabor...day reported at the American College of,Cardiology... artery,disease (CAD) and both oxidized phospholip... on pro-inflammatory variants of the,interleukin-1...uence of Oxidized,Phospholipids and Lp(a) Lipoprot...
Other Medicine Technology:CSL Therapy That Mimics “Good” Cholesterol May Reduce,Plaque Volume in Coronary Arteries 2CSL Therapy That Mimics “Good” Cholesterol May Reduce,Plaque Volume in Coronary Arteries 3ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 2ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 3
... of deflectable curve catheters designed to specif...r patients with small anatomies. Each catheter is ... the finest materials. A unique multi-step process...ion technologies results in the excellent torque a...
... of fixed curve catheters designed to specifically...ents with small anatomies. Each catheter is handcr...inest materials. A unique multi-step process that ...chnologies results in the excellent torque and fle...
4Fr, 5Fr & 6Fr diagnostic electrophysiology catheters with fixed curves.
Inquiry 4Fr, 5Fr and 6Fr diagnostic electrophysiology catheters offer simple, precise distal control with it's patented Easy-Hand steering mechanism.
Medicine Products: